Biohaven enrolls first patient in Phase 3 Clinical Trial to assess Rimegepant Zydis ODT to treat Migraine Read more
Apexigen and Pediatric Brain Tumor Consortium collaborate to evaluate APX005M in Brain tumor children Read more
FDA sanctions AFIA for detecting antibodies to Babesia microti and Imugen Babesia microti NAT Read more